Matches in SemOpenAlex for { <https://semopenalex.org/work/W3007129262> ?p ?o ?g. }
- W3007129262 endingPage "S81" @default.
- W3007129262 startingPage "S61" @default.
- W3007129262 abstract "A. ACUTE HYPERCAPNIC RESPIRATORY FAILURE A1. Acute Exacerbation of COPD: Recommendations: NIV should be used in management of acute exacerbation of COPD in patients with acute or acute-on-chronic respiratory acidosis (pH = 7.25-7.35). (1A) NIV should be attempted in patients with acute exacerbation of COPD (pH <7.25 & PaCO2 ≥ 45) before initiating invasive mechanical ventilation (IMV) except in patients requiring immediate intubation. (2A). Lower the pH higher the chance of failure of NIV. (2B) NIV should not to be used routinely in normo- or mildly hyper-capneic patients with acute exacerbation of COPD, without acidosis (pH > 7.35). (2B) A2. NIV in ARF due to Chest wall deformities/Neuromuscular diseases: Recommendations: NIV may be used in patients of ARF due to chest wall deformity/Neuromuscular diseases. (PaCO2 ≥ 45) (UPP) A3. NIV in ARF due to Obesity hypoventilation syndrome (OHS): Recommendations: NIV may be used in AHRF in OHS patients when they present with acute hypercapnic or acute on chronic respiratory failure (pH 45). (3B) NIV/CPAP may be used in obese, hypercapnic patients with OHS and/or right heart failure in the absence of acidosis. (UPP) B.B1. NIV in Acute Cardiogenic Pulmonary Oedema: Recommendations: NIV is recommended in hospital patients with ARF, due to Cardiogenic pulmonary edema. (1A). NIV should be used in patients with acute heart failure/ cardiogenic pulmonary edema, right from emergency department itself. (1B) Both CPAP and BiPAP modes are safe and effective in patients with cardiogenic pulmonary edema. (1A). However, BPAP (NIV-PS) should be preferred in cardiogenic pulmonary edema with hypercapnia. (3A) B2. NIV in acute hypoxemic respiratory failure: Recommendations: NIV may be used over conventional oxygen therapy in mild early acute hypoxemic respiratory failure (P/F ratio <300 and >200 mmHg), under close supervision. (2B) We strongly recommend against a trial of NIV in patients with acute hypoxemic failure with P/F ratio <150. (2A) B3. NIV in ARF due to Chest Trauma: Recommendations: NIV may be used in traumatic flail chest along with adequate pain relief. (3B) B4. NIV in Immunocompromised Host: Recommendations: In Immunocompromised patients with early ARF, we may consider NIV over conventional oxygen. (2B). B5. NIV in Palliative Care: Recommendations: We strongly recommend use of NIV for reducing dyspnea in palliative care setting. (2A) B6. NIV in post-operative cases: Recommendations: NIV should be used in patients with post-operative acute respiratory failure. (2A) B6a. NIV in abdominal surgery: Recommendations: NIV may be used in patients with ARF following abdominal surgeries. (2A) B6b. NIV in bariatric surgery: Recommendations: NIV may be used in post-bariatric surgery patients with pre-existent OSA or OHS. (3A) B6c. NIV in Thoracic surgery: Recommendations: In cardiothoracic surgeries, use of NIV is recommended post operatively for acute respiratory failure to improve oxygenation and reduce chance of reintubation. (2A) NIV should not be used in patients undergoing esophageal surgery. (UPP) B6d. NIV in post lung transplant: Recommendations: NIV may be used for shortening weaning time and to avoid re-intubation following lung transplantation. (2B) B7. NIV during Procedures (ETI/Bronchoscopy/TEE/Endoscopy): Recommendations: NIV may be used for pre-oxygenation before intubation. (2B) NIV with appropriate interface may be used in patients of ARF during Bronchoscopy/Endoscopy to improve oxygenation. (3B) B8. NIV in Viral Pneumonitis ARDS: Recommendations: NIV cannot be considered as a treatment of choice for patients with acute respiratory failure with H1N1 pneumonia. However, it may be reasonable to use NIV in selected patients with single organ involvement, in a strictly controlled environment with close monitoring. (2B) B9. NIV and Acute exacerbation of Pulmonary Tuberculosis: Recommendations: Careful use of NIV in patients with acute Tuberculosis may be considered, with effective infection control precautions to prevent air-borne transmission. (3B) B10. NIV after planned extubation in high risk patients: Recommendation: We recommend that NIV may be used to wean high risk patients from invasive mechanical ventilation as it reduces re-intubation rate. (2B) B11. NIV for respiratory distress post extubation: Recommendations: We recommend that NIV therapy should not be used to manage respiratory distress post-extubation in high risk patients. (2B) C.Recommendation: Choice of mode should be mainly decided by factors like disease etiology and severity, the breathing effort by the patient and the operator familiarity and experience. (UPP) We suggest using flow trigger over pressure triggering in assisted modes, as it provides better patient ventilator synchrony. Especially in COPD patients, flow triggering has been found to benefit auto PEEP. (3B) D.D1. Sedation: Recommendations: A non-pharmacological approach to calm the patient (Reassuring the patient, proper environment) should always be tried before administrating sedatives. (UPP) In patients on NIV, sedation may be used with extremely close monitoring and only in an ICU setting with lookout for signs of NIV failure. (UPP) E.Recommendations: We recommend that portable bilevel ventilators or specifically designed ICU ventilators with non-invasive mode should be used for delivering Non-invasive ventilation in critically ill patients. (UPP) Both critical care ventilators with leak compensation and bi-level ventilators have been equally effective in decreasing the WOB, RR, and PaCO2. (3B) Currently, Oronasal mask is the most preferred interface for non-invasive ventilation for acute respiratory failure. (3B) F.Recommendations: We recommend that weaning from NIV may be done by a standardized protocol driven approach of the unit. (2B) How to cite this article: Chawla R, Dixit SB, Zirpe KG, Chaudhry D, Khilnani GC, Mehta Y, et al. ISCCM Guidelines for the Use of Non-invasive Ventilation in Acute Respiratory Failure in Adult ICUs. Indian J Crit Care Med 2020;24(Suppl 1):S61-S81." @default.
- W3007129262 created "2020-03-06" @default.
- W3007129262 creator A5001025608 @default.
- W3007129262 creator A5004602741 @default.
- W3007129262 creator A5014533497 @default.
- W3007129262 creator A5017466227 @default.
- W3007129262 creator A5018795245 @default.
- W3007129262 creator A5021198421 @default.
- W3007129262 creator A5022126450 @default.
- W3007129262 creator A5022941145 @default.
- W3007129262 creator A5025378254 @default.
- W3007129262 creator A5026176218 @default.
- W3007129262 creator A5026490909 @default.
- W3007129262 creator A5026808117 @default.
- W3007129262 creator A5040629209 @default.
- W3007129262 creator A5049098692 @default.
- W3007129262 creator A5061602567 @default.
- W3007129262 creator A5064739238 @default.
- W3007129262 creator A5069437145 @default.
- W3007129262 creator A5074284526 @default.
- W3007129262 creator A5078938216 @default.
- W3007129262 creator A5090006917 @default.
- W3007129262 date "2019-12-01" @default.
- W3007129262 modified "2023-10-16" @default.
- W3007129262 title "ISCCM Guidelines for the Use of Non-invasive Ventilation in Acute Respiratory Failure in Adult ICUs" @default.
- W3007129262 cites W1432241 @default.
- W3007129262 cites W1567657152 @default.
- W3007129262 cites W1572143625 @default.
- W3007129262 cites W1599413737 @default.
- W3007129262 cites W1600760067 @default.
- W3007129262 cites W1623340758 @default.
- W3007129262 cites W1626928636 @default.
- W3007129262 cites W1650125492 @default.
- W3007129262 cites W1734241116 @default.
- W3007129262 cites W1737075932 @default.
- W3007129262 cites W176622793 @default.
- W3007129262 cites W1773810762 @default.
- W3007129262 cites W1790602952 @default.
- W3007129262 cites W1833382012 @default.
- W3007129262 cites W1835381198 @default.
- W3007129262 cites W189698948 @default.
- W3007129262 cites W1913480475 @default.
- W3007129262 cites W1922120322 @default.
- W3007129262 cites W1936262166 @default.
- W3007129262 cites W1938806933 @default.
- W3007129262 cites W1949422787 @default.
- W3007129262 cites W1963650240 @default.
- W3007129262 cites W1967255384 @default.
- W3007129262 cites W1973972675 @default.
- W3007129262 cites W1975803576 @default.
- W3007129262 cites W1976885736 @default.
- W3007129262 cites W1983828375 @default.
- W3007129262 cites W1986096796 @default.
- W3007129262 cites W1987046498 @default.
- W3007129262 cites W1987076615 @default.
- W3007129262 cites W1989113117 @default.
- W3007129262 cites W2000744408 @default.
- W3007129262 cites W2000855479 @default.
- W3007129262 cites W2003243751 @default.
- W3007129262 cites W2003271850 @default.
- W3007129262 cites W2007780058 @default.
- W3007129262 cites W2009433076 @default.
- W3007129262 cites W2009900686 @default.
- W3007129262 cites W2015022520 @default.
- W3007129262 cites W2017424202 @default.
- W3007129262 cites W2018216979 @default.
- W3007129262 cites W2022309184 @default.
- W3007129262 cites W2022338399 @default.
- W3007129262 cites W2022762722 @default.
- W3007129262 cites W2024471701 @default.
- W3007129262 cites W2024984110 @default.
- W3007129262 cites W2025903786 @default.
- W3007129262 cites W2033298901 @default.
- W3007129262 cites W2033459955 @default.
- W3007129262 cites W2039200764 @default.
- W3007129262 cites W2039537782 @default.
- W3007129262 cites W2040929424 @default.
- W3007129262 cites W2043497961 @default.
- W3007129262 cites W2043723454 @default.
- W3007129262 cites W2048635636 @default.
- W3007129262 cites W2049786759 @default.
- W3007129262 cites W2052041089 @default.
- W3007129262 cites W2056677551 @default.
- W3007129262 cites W2058384678 @default.
- W3007129262 cites W2059315107 @default.
- W3007129262 cites W2061814948 @default.
- W3007129262 cites W2065191289 @default.
- W3007129262 cites W2065529767 @default.
- W3007129262 cites W2065916460 @default.
- W3007129262 cites W2070800902 @default.
- W3007129262 cites W2072149071 @default.
- W3007129262 cites W2073755185 @default.
- W3007129262 cites W2081154931 @default.
- W3007129262 cites W2082712670 @default.
- W3007129262 cites W2085645268 @default.
- W3007129262 cites W2089182835 @default.
- W3007129262 cites W2092433275 @default.
- W3007129262 cites W2092627876 @default.